Publications
Medications in Single-Dose Vials and Implications of Discarded Injectable Drugs
Published date: March 9, 2021
Jim Jorgenson and Fred Massoomi responded to the article, “Medications in Single-Dose Vials and Implications of Discarded Injectible Drugs” published in JAMA on 2/25/2021. “Formalizing the use of ONB labeled CSTDs to support DVO is a viable option to safely reduce waste of single use products. Currently the major impediment to DVO use is lack of support by FDA and accreditation bodies. FDA and USP should review existing research and develop standards and best practices for the use of CSTDs for drug vial optimization for a safe program that minimizes the waste of medications.”
Citation: JAMA. Published online February 25, 2021. doi:10.1001/jama.2021.2414
Share this: